Your browser doesn't support javascript.
loading
Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells.
Engelen, Suzanne E; Ververs, Francesca A; Markovska, Angela; Lagerholm, B Christoffer; Kraaijenhof, Jordan M; Yousif, Laura Ie; Zurke, Yasemin-Xiomara; Gulersonmez, Can Mc; Kooijman, Sander; Goddard, Michael; van Eijkeren, Robert J; Jervis, Peter J; Besra, Gurdyal S; Haitjema, Saskia; Asselbergs, Folkert W; Kalkhoven, Eric; Ploegh, Hidde L; Boes, Marianne; Cerundolo, Vincenzo; Hovingh, G K; Salio, Mariolina; Stigter, Edwin Ca; Rensen, Patrick Cn; Monaco, Claudia; Schipper, Henk S.
Afiliação
  • Engelen SE; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
  • Ververs FA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Markovska A; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Lagerholm BC; Wolfson Imaging Centre, Medical Research Council (MRC) Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Kraaijenhof JM; Department of Vascular Medicine, Amsterdam Medical Center, Amsterdam, Netherlands.
  • Yousif LI; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
  • Zurke YX; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
  • Gulersonmez CM; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
  • Kooijman S; Division of Endocrinology and Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Medicine, Leiden University Medical Center, Leiden, Netherlands.
  • Goddard M; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
  • van Eijkeren RJ; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
  • Jervis PJ; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
  • Besra GS; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
  • Haitjema S; Central Diagnostic Laboratory and.
  • Asselbergs FW; Division of Heart & Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Kalkhoven E; Institute of Cardiovascular Science and Institute of Health Informatics, Faculty of Population Health Sciences, University College London (UCL), London, United Kingdom.
  • Ploegh HL; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
  • Boes M; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Cerundolo V; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Hovingh GK; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Salio M; Department of Vascular Medicine, Amsterdam Medical Center, Amsterdam, Netherlands.
  • Stigter EC; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Rensen PC; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
  • Monaco C; Division of Endocrinology and Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Medicine, Leiden University Medical Center, Leiden, Netherlands.
  • Schipper HS; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
JCI Insight ; 8(9)2023 05 08.
Article em En | MEDLINE | ID: mdl-36976644
ABSTRACT
Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind glycosylceramides structurally similar to lipid antigens, we hypothesized that circulating lipoproteins form complexes with foreign lipid antigens. In this study, we used 2-color fluorescence correlation spectroscopy to show, for the first time to our knowledge, stable complex formation of lipid antigens α-galactosylceramide (αGalCer), isoglobotrihexosylceramide, and OCH, a sphingosine-truncated analog of αGalCer, with VLDL and/or LDL in vitro and in vivo. We demonstrate LDL receptor-mediated (LDLR-mediated) uptake of lipoprotein-αGalCer complexes by APCs, leading to potent complex-mediated activation of iNKT cells in vitro and in vivo. Finally, LDLR-mutant PBMCs of patients with familial hypercholesterolemia showed impaired activation and proliferation of iNKT cells upon stimulation, underscoring the relevance of lipoproteins as a lipid antigen delivery system in humans. Taken together, circulating lipoproteins form complexes with lipid antigens to facilitate their transport and uptake by APCs, leading to enhanced iNKT cell activation. This study thereby reveals a potentially novel mechanism of lipid antigen delivery to APCs and provides further insight into the immunological capacities of circulating lipoproteins.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células T Matadoras Naturais Limite: Humans Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células T Matadoras Naturais Limite: Humans Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article